| |
| |
|
| Insider
Information: |
Pomerantz Roger |
| Relationship: |
Director |
| City: |
Chalfont |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
314,251 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$241,997 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
314,251 |
|
|
| Total
Value |
$241,997 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seres Therapeutics, Inc. |
MCRB |
President and CEO, Dir... |
2018-09-07 |
213,976 |
2015-06-26 |
0 |
Premium* |
|
|
Contrafect Corp |
CFRX |
Director |
2017-07-25 |
800 |
2017-07-25 |
0 |
Premium* |
|
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2018-07-20 |
100 |
2018-07-20 |
0 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
Director |
2024-02-25 |
99,375 |
2022-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2024-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
99,375 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
90,341 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
81,307 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,035 |
72,273 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2023-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
63,238 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-11-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
54,204 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-08-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
45,170 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
36,136 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2022-02-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,034 |
27,102 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-09-07 |
4 |
AS |
$9.00 |
$16,291 |
D/D |
(1,810) |
213,976 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-09-06 |
4 |
AS |
$9.04 |
$27,235 |
D/D |
(3,013) |
215,786 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-09-05 |
4 |
AS |
$9.12 |
$86,714 |
D/D |
(9,505) |
218,799 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2018-07-20 |
4 |
B |
$23.00 |
$2,300 |
D/D |
100 |
100 |
2.31 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-11 |
4 |
AS |
$9.01 |
$9,099 |
D/D |
(1,010) |
228,304 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-11 |
4 |
OE |
$0.71 |
$717 |
D/D |
1,010 |
229,314 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-10 |
4 |
AS |
$9.05 |
$54,208 |
D/D |
(5,989) |
228,304 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-10 |
4 |
OE |
$0.71 |
$4,252 |
D/D |
5,989 |
234,293 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-09 |
4 |
OE |
$0.71 |
$7,797 |
D/D |
10,981 |
239,285 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-09 |
4 |
AS |
$9.14 |
$100,351 |
D/D |
(10,981) |
228,304 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-06 |
4 |
AS |
$9.14 |
$140,507 |
D/D |
(15,366) |
228,304 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-07-06 |
4 |
OE |
$0.71 |
$10,910 |
D/D |
15,366 |
243,670 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-06-29 |
4 |
AS |
$9.10 |
$40,915 |
D/D |
(4,496) |
228,304 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-06-29 |
4 |
OE |
$0.71 |
$3,192 |
D/D |
4,496 |
232,800 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-06-28 |
4 |
OE |
$0.71 |
$15,308 |
D/D |
21,560 |
249,864 |
0 |
- |
|
| MCRB |
Seres Therapeutics, Inc. |
President and CEO |
• • – |
2018-06-28 |
4 |
AS |
$9.15 |
$197,375 |
D/D |
(21,560) |
228,304 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
